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Alan P Bailey1,2*, Alexandra G Parker1,2, Lauren A Colautti1,2, Laura M Hart3, Ping Liu1,2 and Sarah E Hetrick1,2Abstract: Eating disorders often develop during adolescence and young adulthood, and are associated with
significant psychological and physical burden. Identifying evidence-based interventions is critical and there is need
to take stock of the extant literature, to inform clinical practice regarding well-researched interventions and to direct
future research agendas by identifying gaps in the evidence base.
Aim: To investigate and quantify the nature and distribution of existing high-quality research on the prevention
and treatment of eating disorders in young people using evidence mapping methodology.
Method: A systematic search for prevention and treatment intervention studies in adolescents and young adults
(12–25 years) was conducted using EMBASE, PSYCINFO and MEDLINE. Studies were screened and mapped
according to disorder, intervention modality, stage of eating disorder and study design. Included studies were
restricted to controlled trials and systematic reviews published since 1980.
Results: The eating disorders evidence map included 197 trials and 22 systematic reviews. Prevention research was
dominated by trials of psychoeducation (PE). Bulimia nervosa (BN) received the most attention in the treatment
literature, with cognitive behavioural therapy (CBT) and antidepressants the most common interventions. For
anorexia nervosa (AN), family based therapy (FBT) was the most studied. Lacking were trials exploring treatments for
binge eating disorder (BED) and eating disorder not otherwise specified (EDNOS). Relapse prevention strategies
were notably absent across the eating disorders.
Conclusions: Despite substantial literature devoted to the prevention and treatment of eating disorders in young
people, the evidence base is not well established and significant gaps remain. For those identified as being at-risk,
there is need for prevention research exploring strategies other than passive PE. Treatment interventions targeting
BED and EDNOS are required, as are systematic reviews synthesising BN treatment trials (e.g., CBT, antidepressants).
FBTs for AN require investigation against other validated psychological interventions, and the development of
relapse prevention strategies is urgently required. By systematically identifying existing interventions for young
people with eating disorders and exposing gaps in the current literature, the evidence map can inform researchers,
funding bodies and policy makers as to the opportunities for future research.
Keywords: Eating disorders, Treatment, Prevention, Evidence mapping, Adolescent, Young adultIntroduction
Adolescence and young adulthood is recognized as a
period of heightened risk for the development of eating
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reproduction in any medium, provided the orcases and 50% of binge eating disorder (BED) and eating
disorder not otherwise specified (EDNOS) cases onset be-
fore the age of 22 [1,2]. Eating disorders are recognised as
a significant public health issue with Australian data indi-
cating that they represent the second leading cause of dis-
ability due to mental disorder in females aged 10–24 years
[3]. The psychological, social and physical ramifications of
eating disorders are severe [4,5]. A recent meta-analysis
showed mortality rates to be twice as high in those with
BN and EDNOS and close to six times higher in people
with AN when compared to expected population mortality
rates [6]. Suicide contributes significantly to these hightd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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with eating disorders [7-9]. Comorbidity with depression,
anxiety and substance use disorders is common [10-13],
adding significantly to the burden. Additionally, the esti-
mated financial cost associated with disability-adjusted life
years attributable to eating disorders is higher than that of
depression and anxiety combined [14].
Given the severity and burden associated with eating dis-
orders, and the particular vulnerability across the adoles-
cent and young adult period, there is pressing need to both
develop, and encourage the uptake of, evidence-based pre-
vention and intervention strategies with this population.
Despite the need, and consistent with mental health re-
search generally [15], evidence-based interventions are far
from universally delivered in the clinical management of
eating disorders [16-19]. For example, cognitive behav-
ioural therapy (CBT) is recognised as an empirically sup-
ported intervention and the ‘treatment of choice’ for BN
[20-22], yet surveys of clinicians indicate a majority do not
use CBT as their primary psychological treatment choice
[23,24]. This highlights a significant evidence-practice gap.
A commonly cited barrier to incorporating evidence into
daily clinical practice is the time and resources required to
navigate the large volume of extant research literature
(e.g., [25]). This points to the need for translational tools
that make these vast bodies of literature accessible, digest-
ible and usable. One such approach to knowledge transla-
tion and exchange is evidence mapping; an established
methodology for collating and summarising the literature
in a manner that enables the breadth of the research activ-
ity in a particular field to be explored (e.g., [26-28]). Evi-
dence maps are based on an explicit research question
relating to the field of enquiry, which drives the search for,
and collection of, appropriate studies utilising explicit, sys-
tematic and reproducible methods [29-32]. The key differ-
ence from a systematic review is that the purpose of
evidence mapping is to provide a broad overview of exist-
ing research, with the view to identifying evidence, and
therefore does not include an in-depth quality appraisal
and synthesis of the findings [30]. The end-user may be: 1)
Researchers or research funding bodies who can utilise the
gaps in the evidence highlighted in the evidence map to
drive their research agenda; 2) Policy makers who can use
the evidence map to inform policy decisions; and 3) Clini-
cians who can quickly and easily access information about
interventions.
This paper presents the results of an evidence map we
conducted on eating disorders in adolescents and young
adults. The extent, range and nature of high-quality clin-
ical research interventions for eating disorders in this
population is summarised, gaps in the evidence base are
identified and opportunities for future research are dis-
cussed. This process of taking stock of the evidence is an
essential first step in collating the breadth of researchactivity in an area before further exploring the effective-
ness of interventions.
Methods and materials
The eating disorder evidence map was produced as part of
a larger evidence-mapping project undertaken by the
Centre of Excellence (CoE) in Youth Mental Health (part
of headspace; the Australian National Youth Mental Health
Foundation). A detailed description of the methodology for
evidence mapping has been published elsewhere [31];
methods specific to the eating disorder map are provided
below.
Creating a map based on broad clinical questions relating
to the field of enquiry
After consultation with expert youth mental health re-
searchers and clinicians working within the eating disor-
ders field at Orygen Youth Health Research Centre and
headspace, the questions and scope of the mapping project
were defined. This process revealed two critical questions:
i. What evidence exists regarding interventions for
eating disorders in the youth population?
ii. What areas are, and are not, well researched?
Defining key variables, specifying characteristics to be
mapped and developing inclusion and exclusion criteria
Based on these explicit questions, the characteristics of
studies to be included in the map were defined, which
included specifying the population, stage of eating dis-
order, measured outcomes and study design.
Population
Included trials were required to have participants with a
mean age between 12 and 25 years as their sample, or
where the author specified an adolescent and/or young
adult population. Studies with both adult and adolescent
participants were included if the mean age of any interven-
tion group was 25 years or under. Studies that recruited
participants on the basis of physiological or medical condi-
tions (e.g., changes in eating behaviours induced by brain
tumour) were excluded.
Stage of eating disorder and outcomes
Prevention, treatment intervention and relapse prevention
studies were all included. Prevention trials were categorised
as universal or at-risk prevention. Universal interventions
were those delivered to a designated population regardless
of their risk (e.g., all school students); whereas at-risk pre-
vention interventions were those delivered to either mem-
bers of a population with an established risk factor for the
development of an eating disorder (e.g., athletes) or in-
dividuals with signs or symptoms of a disorder such that
participants were recruited on the basis of elevated risk
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order [33].
Studies including those with an established eating dis-
order diagnosis, classified by the diagnostic and statistical
manual of mental disorders (DSM) [34] or the inter-
national classification of diseases (ICD) [35], were in-
cluded where the treatment intervention was “anything
delivered for the purpose of relieving symptomatology
or improving functioning of the target disorder” [31].
These intervention studies were classified as ‘estab-
lished eating disorder’.
Relapse prevention studies were included if the authors
specified the intervention was designed to prevent relapse,
or to maintain improvements in individuals with eating
disorders who had previously responded to treatment.
Finally, included trials had to measure a specific eating
disorder outcome, for example body mass index (BMI),
eating disorder symptom measure, binge/purge frequency.
Study design
Our map utilised evidence from randomised controlled
trials (RCT), controlled clinical trials (CCT), systematic
reviews and meta-analyses, as these are considered the
most robust study designs for examining the effectiveness
of interventions [36]. Definitions of review types are not
consistent and many different terms are used, at times
interchangeably [29], therefore we included those reviews
providing both a systematic search strategy and the re-
levant data-bases searched. Additionally reviews had to
meet the criteria outlined above. Studies published in
English from 1980 to December 2012 were included.
Searching the literature
Search strategies appropriate for each of the MEDLINE,
PSYCINFO and EMBASE databases were devised using
terms such as “eating disorder”, “controlled trial” and
“review”. Additional terms identified by experts were
also included.
Searches targeted the pre-defined inclusion criteria by
combining terms describing: type of eating disorder, study
methodology and stage of eating disorder (the full search
strategy is available upon request to the corresponding
author). Search strategies were revised after a random
sample of 100 citations was examined and after cross-
checking that the search strategy retrieved 20 articles
known to meet the inclusion criteria.
Screening and positioning the relevant evidence within the
map (charting)
Two authors independently screened 100 references ran-
domly selected from the search results to determine the
consistency of applying the inclusion/exclusion criteria
(inter-rater reliability > 0.90 was achieved). Two authors
then screened all retrieved references and where a titleor abstract reported a trial that appeared to be eligible
for inclusion, the full article was obtained and assessed
against the inclusion and exclusion criteria.
Studies meeting the inclusion criteria were coded by one
author and double coded independently by a second au-
thor. Discrepancies were discussed and consensus reached.
Studies were coded according to: 1. Type of eating dis-
order; 2. Type of intervention; 3. Stage of eating disorder;
and 4. Study design. Type of eating disorder was coded as
AN, BN, EDNOS or BED, according to author report of
participant classification. Type of intervention was classi-
fied as psychological, biological and service/delivery im-
provement. Stage of eating disorder was coded as universal
prevention, at-risk, established eating disorder and relapse
prevention. Study designs were coded as RCT/CCT (here-
after referred to as ‘trials’) and systematic review/meta ana-
lysis (hereafter referred to as ‘reviews’).
Studies that evaluated the effectiveness of more than
one type of intervention or eating disorder classification
were double coded for each intervention and classifica-
tion, thus the sum of trials from each coded section is
greater than the total number of included studies. The
primary reference for each study was established with
secondary publications indicated as such. This process
prevented counting one trial multiple times and misre-
presenting the number of studies in a particular area. In
addition to these codes, a qualitative description of the
interventions used in each trial was recorded. For the
purposes of this paper, where a review was available and
included in the map, a short synthesis of the main find-
ings has been provided.
Review
Included trials
Database searches were conducted in February of 2013
and our strategies identified 8,856 references, of which
229 met the predefined inclusion criteria based on title,
abstract and full text screening (see Figure 1). The 229
publications included in the final map consisted of 22 re-
views, 197 trials and 10 follow-up studies. A list of cita-
tions for all included studies in the map is available on
request or from our online searchable database (see [37]).
Interventions for prevention
A total of 52 universal prevention studies were identified
(46 trials; 6 reviews). Of the 46 trials, psychoeducation
based programs were the most common (n = 26), followed
by cognitive dissonance (n = 6) and cognitive behavioural
based (n = 5) programs. The remaining trials investigated
non-specific psychological strategies such as media literacy
training, writing tasks and school-based prevention
programs.
A total of 46 prevention studies for at-risk populations
were identified (40 trials; 6 reviews). Of the trials,
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Figure 1 Flow chart of included studies.
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based (n = 12) programs were most common, followed by
cognitive-behavioural based programs (n = 7). Other non-
specific psychological intervention trials included multicom-
ponent school based programs, media literacy training,
writing tasks, relaxation and yoga. Table 1 displays the
complete distribution of identified studies for prevention
in both universal and at-risk populations.Table 1 Distribution of included prevention studies
Intervention Trial
Universal prevention
Psychological Cognitive dissonance 6
Psychoeducation based 26
Cognitive/Behavioural based 5
Psychological - other 14
Psychological - general
At-risk prevention
Psychological Cognitive dissonance 12
Psychoeducation based 12
Cognitive/Behavioural based 7
Motivational interviewing 1
Psychological - other 18
Psychological - general
Legend: AN=anorexia nervosa, BN=bulimia nervosa, BED=binge eating disorder, EDReviews summarising prevention programs for both uni-
versal and at-risk populations indicate the evidence for their
effectiveness is modest and not without significant limita-
tions [38-43]. Meta-analyses of controlled trials indicate
prevention programs generally produce large effects on out-
comes related to eating disorder knowledge, and only small
net effects for other important prevention targets such as
reducing exhibited risk factors, changing attitudes andAN BN BED EDNOS ED Review
6
26
5 1
1 13 1
4
12
2 10
1 6 1
1 1 1
3 2 13 1
4
NOS=eating disorder not otherwise specified, ED=eating disorder general.
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for and identification of moderating factors that may lead
to larger prevention effects, for example targeting high-risk
populations versus universal, utilising active programs deliv-
ered in interactive formats versus passive didactic programs
(e.g., psychoeducation) and multisession programs versus
single session (see [39,42]). Promising preventative effects
are generally exhibited directly following program delivery
and over the immediate short-term, however little work has
been done investigating whether effects are sustained long-
term. This lack of follow-up testing combined with the lim-
ited use of standardised eating pathology measures andTable 2 Distribution of included disorder established treatme
Intervention Trial
Psychological Cognitive & behavioural therapies 27
Psychoeducation 10
Family based therapy (FBT) 15
Supportive therapy 3
Psychodynamic/Psychoanalysis 5
Motivational interview/enhancement 4
Exposure therapy 2
Interpersonal therapy 2
Dialectical behavioural therapy 1
Eye movement desens. & reprocessing 1
Psychological - other 27
Psychological - general
Biological SSRI 15
TCA 10
SNRI 1
MAOI 1
Appetite moderator 6
Anticonvulsant 1
Typical antipsychotic 1
Atypical antipsychotic 6
Lithium 2
Antidepressant - other (trazodone) 1
Opioid antagonist (naltrexone) 1
Neutraceutical (inositol) 1
Transcranial magnetic stimulation 1
Re-feeding 2
Biological - other 4
Biological - general
Service Service/Delivery improvement 6
Legend: AN=anorexia nervosa, BN=bulimia nervosa, BED=binge eating disorder, ED
reuptake inhibitor, TCA=tricyclic antidepressant, SNRI=serotonin norepinephrine reudiagnostic criteria makes it difficult to accurately conclude
on the preventative effects of most evaluated programs.
Interventions for an established eating disorder
A total of 129 studies investigating interventions for estab-
lished eating disorders were identified (see Table 2), of which
77 involved psychological interventions (67 trials; 10 reviews),
54 involved biological interventions (47 trials; 7 reviews).
Psychological interventions for established eating disorders
Of the identified studies investigating psychological in-
terventions, the most common strategy for diagnosednt studies
AN BN BED EDNOS Review
3 22 2 5
6 6
12 5 2 5
1 3
1 3 1
2 3 1 3
2
2
1
1 1 1
14 18 2 6
4
4 9 1 1
3 8
1
1
1 5 1
1
1 2
6 1 3
1 1
1
1
1 1
1
2
3 1
4
3 4 1
NOS=eating disorder not otherwise specified, SSRI=selective serotonin
ptake inhibitor, MAOI=monoamine oxidase inhibitor.
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For diagnosed BN, trials were dominated by cognitive
behavioural therapy (CBT, n = 22) with a smaller number
investigating FBT (n = 5). Psychological intervention tri-
als for EDNOS and BED were scarce in comparison.
Table 2 displays the complete distribution of identified
studies by type of psychological intervention and type of
disorder.
Included reviews of psychological interventions for diag-
nosed eating disorders were restricted to syntheses of fam-
ily based therapies (FBT) for AN, with one review also
including BN [44-50]. FBT as defined in this paper and
summarised in included reviews refers to any intervention
where the family constitutes a core intervention compo-
nent. The most commonly evaluated models include the
Maudsley Model [51] and its variants and a highly similar
modality called behavioural family systems therapy [52].
Reviews highlight the growing evidence base for FBT in
AN, providing summaries of RCTs which support its pos-
ition in clinical guideline recommendations as a first line
treatment. Evidence indicates that FBTs are generally ef-
fective with reviews indicating up to half of adolescents
receiving the intervention achieving remission. A smaller
subset of studies has noted higher rates of remission at
follow-up for FBT compared to individual level interven-
tions. FBT also appears to be more effective for younger
adolescents and those with a shorter duration of illness,
however the majority of trials only report mean partici-
pant ages in the 12–18 range. It should be noted that these
findings come only from a small number of trials with
small sample sizes, where risk of bias is notable. Nonethe-
less, syntheses from the included reviews provide mostly
supportive conclusions for FBT as an effective treatment
for AN in young people.
A single recently published review of FBTs investi-
gated this modality in BN [47], summarising two extant
RCTs. The first trial found higher remission rates for FBT
versus individual supportive therapy at post-treatment and
6 months [53]; the second trial found higher binge abstin-
ence rates for CBT guided self-care versus FBT at post-
treatment but no differences at 6 months [54]. FBT is
promising but requires further verification in BN before
stronger recommendations about its effectiveness can be
made. No reviews of other psychological interventions for
BN were identified. Similarly reviews for BED and EDNOS
were absent.
Biological interventions for established eating disorders
Of the identified studies investigating biological inter-
ventions, medications were the most common. For diag-
nosed BN, selective serotonin reuptake inhibitors (SSRI,
n = 9) and tricyclic antidepressants (TCA, n = 8) were
the most investigated. For diagnosed AN, antipsychotics
(7 trials; 3 reviews) were the most common, followed bySSRIs (n = 4). Biological interventions for EDNOS and
BED were almost non-existent. Table 2 displays the
complete distribution of identified studies by type of bio-
logical intervention and type of disorder.
Included reviews synthesised findings from controlled
medication trials and were restricted to investigations of
antipsychotics in AN [55-57] and general medication re-
views including analyses of antidepressants for AN and
BN [58,59]. Reviews of controlled medication trials for
EDNOS and BED in our population were absent.
Antipsychotics for AN were synthesized by meta ana-
lysis (mean age 22 years across 8 RCTs [56]), with findings
indicating no advantage over placebo or treatment as
usual in terms of weight gain or symptom improvement.
General medication reviews did not identify any trials
investigating antidepressants in adolescents (12–18 years)
[58,59]. While trials exist in the younger adult popula-
tion (18–25 years), these were lost within broad adult
level syntheses. For adult AN, the use of both TCAs and
SSRIs has not produced encouraging results [58], with
safety issues and lack of effectiveness data making trans-
lation to younger populations problematic. For adult BN,
SSRIs have produced positive findings with moderate ef-
fects on binge/purge frequency and reviews indicate their
potential utility with young people [58,59]. However this
needs to be balanced with the lack of current efficacy and
safety data in this younger population, particularly given
the controversy surrounding the use of SSRIs with adoles-
cents and young adults in the depression field (see [60]).
The lack of trials in adolescents and the urgent need to
systematically synthesise existing young adult trials means
medication management recommendations are currently
restricted to broad adult level evidence.
Interventions for relapse prevention
Research into relapse prevention among young people
with eating disorders is limited. Only six trials were
identified; five trials in AN (n = 3 CBT; n = 1 psychoedu-
cation; n = 2 SSRI) investigating relapse prevention strat-
egies following successful inpatient weight restoration,
and one trial in BN investigating SSRIs delivered after
successful psychotherapy (see Table 3). No systematic re-
views were identified.
Discussion
The results of the evidence map highlight areas that have
received research attention while simultaneously exposing
numerous opportunities for research in the area of eating
disorder intervention. Gaps in the current evidence base are
discussed with a focus on specific research opportunities.
Research opportunities for prevention
Prevention literature is heavily dominated by education
based programs and while providing information on
Table 3 Distribution of included relapse prevention studies
Intervention Trial AN BN BED EDNOS Review
Psychological Cognitive & behavioural therapies 3 3
Psychoeducation 1 1
Biological SSRI 3 2 1
Legend: AN=anorexia nervosa, BN=bulimia nervosa, BED=binge eating disorder, EDNOS=eating disorder not otherwise specified, SSRI=selective serotonin
reuptake inhibitor.
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these programs are minimally effective in producing be-
haviour change, outside of increasing knowledge [40].
There are suggestions that programs utilising active
prevention components may produce larger effects and
many opportunities exist [39,42].
Cognitive dissonance or dissonance induction is one
such active prevention approach which involves engaging
in counter-attitudinal exercises that target potential risk
factors for eating pathology (e.g., body dissatisfaction and
internalisation of the ‘thin-ideal’) [61]. Research to date in-
dicates these interventions show promise in changing atti-
tudes associated with eating pathology over the short term
[40-42], however further trials involving long term follow-
up are need to determine if lasting effects on standardised
eating pathology outcomes are possible. Media literacy
programs have also shown promise and incorporating ac-
tive dissonance exercises and simple CBT techniques has
the potential to boost preventative effects.
Interestingly, our map failed to identify any controlled
trials investigating prevention strategies involving families.
This is curious given eating disorders often develop in ado-
lescence; a time for many when the family structure is crit-
ical to functioning. Potential prevention components may
involve education and skills-training for parents around
talking about and identifying risk factors. Such compo-
nents may assist in creating awareness, identifying the
early stages of disordered eating or other symptomatology,
ensuring parents have some control over their child’s eat-
ing (particularly in those identified as at-risk) and import-
antly encouraging early help-seeking.
Research opportunities for those with established eating
disorders
Systematic reviews
The evidence map revealed a paucity of systematic reviews
summarising a range of treatment options for young
people across the eating disorders. For example, many tri-
als have now been conducted investigated interventions
for BN such as CBT (22 trials) and SSRIs (9 trials) yet sys-
tematic reviews of these intervention modalities are ab-
sent. Results from individual trials are mixed regarding the
effectiveness of either intervention, suggesting that sub-
mitting the trials to systematic review and meta-analysismay provide a summary answer to the effectiveness ques-
tion. While both CBT and SSRIs have received attention
in the adult literature, with systematic reviews demonstrat-
ing the clinical effectiveness of these approaches [21,62],
the comprehensive synthesis of adolescent and young adult
trial data would provide important clinical guidance about
the appropriateness and effectiveness of these interven-
tions in this younger population.
Stepped-care models of intervention
Stepped care for the management of mental disorders is
not a new concept (e.g., [63-65]) yet these intervention
models have received limited empirical attention in the
field of eating disorders. Our map identified two trials
investigating stepped-care models for the treatment of
BN in young people [66,67]. Both trials compared a self-
help manual with standard CBT in the initial phase, with
those failing to respond being offered modified CBT in
one trial [67] and fluoxetine plus CBT (if still unrespon-
sive) in the second trial [66]. Both trials indicated that a
stepped-care model was as effective as the main CBT
intervention delivered, indicating a potentially lower cost/
less resource intensive intervention model can produce
similar effects.
Stepped care approaches typically commence with low-
intensity treatment components and step up, depending on
response and stage of illness, to more intensive, individua-
lised, clinician delivered strategies. These are considered
advantageous as they can be cost effective in a resource
limited field, reduce delay-to-treat time by offering low-
intensity components such as self-help as an initial step,
and can be tailored to individual treatment plans accord-
ing to illness severity and treatment response [65,68,69].
While these models do show promise, little can be de-
finitively concluded about the effectiveness and appro-
priateness of stepped care interventions for young people
with eating disorders. Significant questions remain regard-
ing how decisions are made about progressing through
intervention ‘steps’ (e.g., using response and/or stage of ill-
ness); appropriateness in younger age groups; how those
who do not respond should be managed; and whether
these models are appropriate for high severity disorders
like AN which typically require intensive, sustained inter-
vention [69]. Given these remaining questions and the
Bailey et al. Journal of Eating Disorders 2014, 2:5 Page 8 of 12
http://www.jeatdisord.com/content/2/1/5potential benefits associated with these models, further re-
search attention is warranted.
Binge eating disorder
Intervention research for BED among the adolescent
and young adult population is lacking. Reviews of the
adult literature point to CBT as a promising intervention
in reducing binge frequency and other associated body
image concerns, however changes in BMI are yet to be
noted [70,71]. The map identified only two small trials
of CBT in the adolescent and young adult population
and while some positive effects on bingeing behaviour
were noted [72,73], it remains difficult to draw conclu-
sions about its appropriateness and effectiveness.
The promising nature of CBT warrants further investi-
gation in the context of a much greater research effort
directed towards BED given it is a stable and chronic
syndrome, with serious physical and psychological rami-
fications including a heightened risk for obesity [74-76].
Despite a marginally later onset than other eating disor-
ders, BED does occur in the younger population [1,2]
highlighting the importance of developing effective inter-
ventions, particularly as adolescence represents a critical
period for the development and maintenance of positive
health behaviours [77].
While we acknowledge that the lack of intervention
studies likely reflects BED’s previous status as a research
category according to DSM-IV-TR [78], it is anticipated
that its inclusion as a diagnostic category in DSM-5 [79]
will provide impetus for further intervention specific re-
search in this area.
Family based therapy
Intervention research is dominated by trials of family based
therapy, particularly for AN in the adolescent bracket. Even
with the widespread implementation of FBTs due to clin-
ical practice guideline recommendations (e.g., [20,80]), fur-
ther well-conducted trials are still required, not only to
provide a stronger evidence base for clinical recommenda-
tions, but to address significant clinical questions that re-
main. For example, is FBT the most effective psychological
intervention for AN? Head to head trials with other vali-
dated psychological interventions adapted for the eating
disorders are required. CBT is a potential candidate given
its success in BN and the evidence base generated across
other adolescent/young adult onset disorders. Interper-
sonal therapy also presents an interesting comparison as
its relationship framework may have overlapping features
with FBT. Important work is also needed to determine the
effectiveness of FBT in populations other than adolescents.
A recent review described developments of an adapted
version of FBT for young adults (18+) [47]. The main
adaptation being the definition of family where a prag-
matic approach is used to define a ‘family of choice’ whichmay include partners, close friends, room mates etc. This
approach has the potential to make an effective interven-
tion available to a wider population.
Eating disorder not otherwise specified
The evidence map highlights the absence of intervention
studies investigating EDNOS treatments in adolescents and
young adults. This is concerning given that data suggest
more than 50% of those diagnosed with an eating disorder
have EDNOS [81,82] and it being the most common diag-
nosis reported in clinical and community populations with
eating disorders [83,84]. Additionally, those with EDNOS
follow a similar course to those diagnosed with AN and
BN in terms of the nature, symptom severity, eating path-
ology and outcome of disorder [85-87].
Due to the similarities EDNOS shares with AN and BN,
and problems recruiting sufficient sample sizes in eating
disorder research [88], it can be common for researchers
to include participants with EDNOS within trials investi-
gating interventions for AN or BN, either by including
EDNOS diagnosis or by using relaxed AN/BN inclusion
criteria which facilitates entry of EDNOS participants. This
may explain the lack of trials specifically targeting those
with EDNOS, potentially masking the evidence base for ef-
fective EDNOS intervention. However, only a small num-
ber of trials explicitly reported doing so and those that did
failed to provide the adequate sub-group analysis required
to determine intervention effects according to eating dis-
order diagnosis.
Given the similarities between EDNOS and AN/BN
categories and in line with guideline recommendations
indicating treatment of EDNOS follow the disorder-
symptom profile most closely resembled (either AN or
BN [20]), those treatments which have previously shown
promise in the AN and BN area (e.g., FBT, CBT) should
be prioritised in future EDNOS intervention research.
Research opportunities for relapse prevention
While rates of relapse have yet to be systematically in-
vestigated, longitudinal cohort and treatment follow-up
studies estimate 20% to 50% of those with eating disor-
ders will relapse [89-94]. Given these high relapse rates
and the burden associated with a relapsing and chronic
long-term condition, as is common among those with
eating disorders, effective relapse prevention strategies
are vital. The lack of trials investigating relapse pre-
vention in adolescents and young adults with eating
disorders is one of the most salient findings of this evi-
dence map.
Three small trials were identified utilising CBT as a re-
lapse prevention strategy with post-hospitalised, weight re-
stored AN participants, showing positive preliminary
results [95-97]. SSRIs were also investigated in another
two trials using similar weight restored samples, however
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that large proportions of intervention arm participants
across these trials still experienced relapse.
CBT-based relapse prevention strategies appear promis-
ing, as noted in the above trials and highlighted in the
adult AN literature [100], but require further investigation.
Newer ‘third wave’ strategies like mindfulness, which has
shown some degree of success in adults with depression
[101,102], are now beginning to receive attention in the
eating disorders literature (e.g., [103-105]) and similarly
require investigation in younger populations. Given the
age of onset of most eating disorders [1,2], it is interesting
that family-based relapse prevention strategies have not
yet been developed. Such strategies are noted in other high
severity disorders affecting young people, for example first
episode psychosis [106] and bipolar disorder [107]. Once a
young person leaves primary treatment, they return to an
environment that is potentially unchanged, where sig-
nificant risk factors remain [108]. The family, and thus
family-based interventions, may be well positioned to
address factors associated with relapse and assert an im-
portant influence in maintaining behaviour change and
preventing or minimising relapse.
Limitations
Syntheses of intervention effects were not undertaken,
restricting us from drawing conclusions on intervention
efficacy. Additionally, study quality appraisal was not con-
ducted; therefore studies with methodological flaws may
still be included. Furthermore, included studies were re-
stricted to ‘gold standard’ research, which neglects import-
ant information available from studies utilising designs
other than controlled trials and systematic reviews. For ex-
ample, research areas where it may be unethical to ran-
domise patients to particular conditions (e.g., those with
chronic and severe disorders) would be absent from the
evidence map. Nonetheless, this evidence map has system-
atically demonstrated what prevention and treatment in-
terventions exist and has exposed important gaps in the
current literature.
Conclusions
The onset of eating disorders frequently occurs in adoles-
cence and young adulthood and is associated with signifi-
cant psychological and physical burden. While promising
interventions for this population have been identified, gaps
exist and the body of evidence has not firmly established
which interventions are most effective. Systematic reviews
are required in some areas where the evidence base has
yet to be summarised in a meaningful way (e.g., the use of
CBT and antidepressants for diagnosed BN). Interventions
which require further investigation in well conducted con-
trolled trials include prevention programs for those at risk
of developing eating disorders, focusing on interventioncomponents other than passive psychoeducation; head-to-
head trials of FBTs and other validated psychotherapies
for AN; investigation of stepped-care intervention models;
psychological interventions for BED and EDNOS; and
interventions designed to prevent relapse or maintain
treatment response. By systematically identifying existing
interventions for young people with eating disorders and
exposing gaps in the current evidence base, this evidence
map can inform researchers, funding bodies and policy
makers as to the opportunities for future research.
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